#iHealth COVID-19 Antigen Rapid Test Tag
The iHealth COVID-19 Antigen Rapid Test is a diagnostic test designed to detect the presence of the SARS-CoV-2 virus. This virus is responsible for COVID-19. This test is intended to provide relatively quick results. Typically within 15-30 minutes, and it is often used for rapid screening and point-of-care testing for the virus.
Key features and details of the iHealth COVID-19 Antigen Rapid Test typically include:
- Antigen Test: It is an antigen test. In other words, it means it detects specific proteins (antigens) on the surface of the SARS-CoV-2 virus. This is different from PCR (polymerase chain reaction) tests, which detect the virus’s genetic material.
- Rapid Results: The test is designed for rapid results, making it suitable for on-the-spot testing in various settings, including healthcare facilities, clinics, and community testing centers.
- Sample Collection: The test typically requires a nasal swab or nasopharyngeal swab sample. This is collected from the individual’s nose.
- User-Friendly: The test is designed to be user-friendly. It has clear instructions for sample collection and testing procedures.
- Sensitivity and Specificity: Like all diagnostic tests, the iHealth COVID-19 Antigen Rapid Test has specific sensitivity and specificity rates, which indicate its accuracy in detecting the virus. These rates can vary, so it’s important to refer to the test’s documentation for details on its performance.
- Emergency Use Authorization (EUA): Tests like the iHealth COVID-19 Antigen Rapid Test often receive Emergency Use Authorization from regulatory agencies like the U.S. Food and Drug Administration (FDA) during public health emergencies like the COVID-19 pandemic.
The availability, features, and performance of specific COVID-19 tests, including the iHealth COVID-19 Antigen Rapid Test, may change over time as new tests are developed, evaluated, and approved.
If you are considering using or administering a COVID-19 test, it’s crucial to follow the most up-to-date guidance from public health authorities and to use tests that have received regulatory approval or emergency use authorization. Additionally, healthcare professionals should be consulted for proper test administration and interpretation of results.